{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:40:16Z","timestamp":1765370416463},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.7759\/cureus.60331","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:57:02Z","timestamp":1715770622000},"source":"Crossref","is-referenced-by-count":2,"title":["Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis"],"prefix":"10.7759","author":[{"given":"Romane","family":"Teshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Saito-Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyo","family":"Hitaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.2.173","article-title":"Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features","volume":"51","author":"Brand CA","year":"1992","unstructured":"Brand CA, Rowley MJ, Tait BD, Muirden KD, Whittingham SF. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis. 1992, 51:173-6. 10.1136\/ard.51.2.173","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.136","article-title":"Coeliac disease and autoimmune disease-genetic overlap and screening","volume":"12","author":"Lundin KE","year":"2015","unstructured":"Lundin KE, Wijmenga C. Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol. 2015, 12:507-15. 10.1038\/nrgastro.2015.136","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei G","year":"2022","unstructured":"Frazzei G, van Vollenhoven RF, de Jong BA, Siegelaar SE, van Schaardenburg D. Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front Immunol. 2022, 13:899372. 10.3389\/fimmu.2022.899372","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.016","article-title":"Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases","volume":"73","author":"Ohata C","year":"2015","unstructured":"Ohata C, Ishii N, Koga H, et al.. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases. J Am Acad Dermatol. 2015, 73:50-5. 10.1016\/j.jaad.2015.03.016","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000435912","article-title":"Pemphigoid diseases as a sign of active psoriasis: a case report and brief review","volume":"231","author":"Iskandarli M","year":"2015","unstructured":"Iskandarli M, Gerceker Turk B, Yaman B, Ozturk G. Pemphigoid diseases as a sign of active psoriasis: a case report and brief review. Dermatology. 2015, 231:319-21. 10.1159\/000435912","journal-title":"Dermatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12070","article-title":"Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia","volume":"53","author":"Choon SE","year":"2014","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014, 53:676-84. 10.1111\/ijd.12070","journal-title":"Int J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20163804","article-title":"Generalized pustular psoriasis induced by systemic steroid dose reduction","volume":"91","author":"Westphal DC","year":"2016","unstructured":"Westphal DC, Schettini AP, Souza PP, Castiel J, Chirano CA, Santos M. Generalized pustular psoriasis induced by systemic steroid dose reduction. An Bras Dermatol. 2016, 91:664-6. 10.1590\/abd1806-4841.20163804","journal-title":"An Bras Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00719-7","article-title":"Management of coexisting bullous pemphigoid and psoriasis: a review","volume":"23","author":"Hsieh CY","year":"2022","unstructured":"Hsieh CY, Tsai TF. Management of coexisting bullous pemphigoid and psoriasis: a review. Am J Clin Dermatol. 2022, 23:869-79. 10.1007\/s40257-022-00719-7","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of spesolimab for generalized pustular psoriasis","volume":"385","author":"Bachelez H","year":"2021","unstructured":"Bachelez H, Choon SE, Marrakchi S, et al.. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021, 385:2431-40. 10.1056\/NEJMoa2111563","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00587-5","article-title":"Targeting IL-36 in inflammatory skin diseases","volume":"37","author":"Fukaura R","year":"2023","unstructured":"Fukaura R, Akiyama M. Targeting IL-36 in inflammatory skin diseases. BioDrugs. 2023, 37:279-93. 10.1007\/s40259-023-00587-5","journal-title":"BioDrugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1042\/BST20211264","article-title":"The role of IL-36 subfamily in intestinal disease","volume":"50","author":"Xu P","year":"2022","unstructured":"Xu P, Guan H, Xiao W, Sun L. The role of IL-36 subfamily in intestinal disease. Biochem Soc Trans. 2022, 50:223-30. 10.1042\/BST20211264","journal-title":"Biochem Soc Trans"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144336","article-title":"IL-36 in chronic inflammation and fibrosis - bridging the gap?","volume":"131","author":"Elias M","year":"2021","unstructured":"Elias M, Zhao S, Le HT, et al.. IL-36 in chronic inflammation and fibrosis - bridging the gap?. J Clin Invest. 2021, 131:10.1172\/JCI144336","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2514","article-title":"An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil SK","year":"2017","unstructured":"Mahil SK, Catapano M, Di Meglio P, et al.. An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Sci Transl Med. 2017, 9:10.1126\/scitranslmed.aan2514","journal-title":"Sci Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa M","year":"2011","unstructured":"Arakawa M, Dainichi T, Ishii N, et al.. Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Exp Dermatol. 2011, 20:1022-4. 10.1111\/j.1600-0625.2011.01378.x","journal-title":"Exp Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13803","article-title":"Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report","volume":"63","author":"Yun JS","year":"2022","unstructured":"Yun JS, Scardamaglia L, Tan CG, McCormack CJ. Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report. Australas J Dermatol. 2022, 63:e155-8. 10.1111\/ajd.13803","journal-title":"Australas J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14760","article-title":"Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid","volume":"46","author":"Kamata M","year":"2019","unstructured":"Kamata M, Asano Y, Shida R, et al.. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. J Dermatol. 2019, 46:e216-7. 10.1111\/1346-8138.14760","journal-title":"J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16765","article-title":"Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: a paradoxical reaction","volume":"50","author":"Wang R","year":"2023","unstructured":"Wang R, Wang A, Wang M. Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: a paradoxical reaction. J Dermatol. 2023, 50:956-9. 10.1111\/1346-8138.16765","journal-title":"J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081298","article-title":"Pustular eruption following COVID-19 vaccination: a narrative case-based review","volume":"11","author":"Karampinis E","year":"2023","unstructured":"Karampinis E, Gravani A, Gidarokosta P, Bogdanos DP, Roussaki-Schulze AV, Zafiriou E. Pustular eruption following COVID-19 vaccination: a narrative case-based review. Vaccines (Basel). 2023, 11:1298. 10.3390\/vaccines11081298","journal-title":"Vaccines (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253556-spesolimab-in-the-management-of-generalized-pustular-psoriasis-with-concurrent-bullous-pemphigoid-and-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:57:05Z","timestamp":1715770625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253556-spesolimab-in-the-management-of-generalized-pustular-psoriasis-with-concurrent-bullous-pemphigoid-and-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.60331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}